You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

FLT-TKD

Showing 1 - 25 of 167
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

AML, Adult, Refractory AML, Relapsed Adult AML Trial in France (AzaCITIDine Oral Tablet, Xospata)

Not yet recruiting
  • AML, Adult
  • +4 more
  • Amiens, France
  • +19 more
Sep 1, 2023

FLT3-ITD Mutation, FLT3/TKD Mutation, PDGFR-Alpha D842V Trial in Genova (Crenolanib besylate)

Available
  • FLT3-ITD Mutation
  • +3 more
  • Crenolanib besylate
  • Genova, Italy
    Ospedale Policlinico San Martino
May 21, 2020

Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Acute Mixed-Phenotype Leukemia Trial in United States (BMF-500)

Not yet recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • Los Angeles, California
  • +9 more
Jun 27, 2023

Acute Myeloid Leukemia Trial in United States (Gilteritinib, Midostaurin, Daunorubicin)

Active, not recruiting
  • Acute Myeloid Leukemia
  • Scottsdale, Arizona
  • +43 more
Nov 17, 2022

AML, Adult Trial in Berne (HDM201, Midostaurin)

Terminated
  • AML, Adult
  • Berne, Switzerland
    Departement of Medical Oncology, University Hospital Berne
Oct 3, 2022

GilteRInf 2022 Study (Gilteritinib Related Infections)

Active, not recruiting
  • Acute Myeloid Leukemia
  • Roma, RM, Italy
    Maria Ilaria Del Principe
Mar 17, 2023

Acute Myeloid Leukemia (AML) With, FLT3 Mutation, Internal Tandem Duplication (ITD) or Tyrosine Kinase Domain (TKD) Trial in

No longer available
  • Acute Myeloid Leukemia (AML) With
  • FLT3 Mutation, Internal Tandem Duplication (ITD) or Tyrosine Kinase Domain (TKD)
  • Phoenix, Arizona
  • +43 more
Jul 14, 2020

Acute Myeloid Leukemia With KMT2A Rearrangement, Acute Myeloid Leukemia With NPM1 Mutation Trial (Biospecimen Collection, Bone

Not yet recruiting
  • Acute Myeloid Leukemia With KMT2A Rearrangement
  • Acute Myeloid Leukemia With NPM1 Mutation
  • Biospecimen Collection
  • +7 more
  • (no location specified)
Jun 1, 2023

Acute Myeloid Leukemia With FLT3/ITD Mutation Trial in Tampa (Gilteritinib, Vyxeos)

Suspended
  • Acute Myeloid Leukemia With FLT3/ITD Mutation
  • Tampa, Florida
    Moffitt Cancer Center
Nov 11, 2022

Italian Non-Interventional Study of FLT3 Mutated AML Patients

Unknown status
  • AML
  • +2 more
  • Clinical and Molecular data collection
  • Ancona, AN, Italy
  • +32 more
Apr 20, 2020

AML, Adult Trial (STI-8591)

Not yet recruiting
  • AML, Adult
  • (no location specified)
Jul 12, 2023

Acute Myeloid Leukemia Trial in France (Dexamethasone)

Active, not recruiting
  • Acute Myeloid Leukemia
  • Angers, France
  • +24 more
Jul 26, 2022

FLT3-ITD Gene Mutation and CD135 Expression in Acute Myeloid

Not yet recruiting
  • Acute Myeloid Leukemia
    • (no location specified)
    May 17, 2022

    Acute Myeloid Leukemia Trial in Gainesville, Saint Louis, Rochester (drug, procedure, device)

    Recruiting
    • Acute Myeloid Leukemia
    • Gainesville, Florida
    • +2 more
    Aug 30, 2022

    Acute Myeloid Leukemia Trial (Gilteritinib 40 MG Oral Tablet, Cladribine, Cytarabine)

    Not yet recruiting
    • Acute Myeloid Leukemia
    • Gilteritinib 40 MG Oral Tablet
    • +4 more
    • Lexington, Kentucky
      University of Kentucky
    Oct 27, 2022

    Acute Myeloid Leukemia With FLT3/ITD Mutation, Acute Myeloid Leukemia With Inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,

    Active, not recruiting
    Has Results
    • Acute Myeloid Leukemia With FLT3/ITD Mutation
    • +5 more
    • Biopsy
    • +7 more
    • Lewes, Delaware
    • +42 more
    Mar 15, 2022

    Acute Myelogenous Leukemia (AML) Trial in Australia (MAX-40279)

    Recruiting
    • Acute Myelogenous Leukemia (AML)
    • Darlinghurst, New South Wales, Australia
    • +3 more
    Jan 18, 2022

    New Cytokine-based Dynamic Stratification Based on FLt3 Ligand

    Recruiting
    • Acute Myeloid Leukemia
    • No intervention
    • Strasbourg, Bas-Rhin, France
    • +24 more
    Aug 25, 2021

    Acute Myeloid Leukemia Trial in Worldwide (Midostaurin)

    Completed
    • Acute Myeloid Leukemia
    • Pleven, Bulgaria
    • +85 more
    Feb 11, 2022

    Anorexia Nervosa in Remission Trial in San Diego (Therapeutic Ketogenic Diet)

    Not yet recruiting
    • Anorexia Nervosa in Remission
    • Therapeutic Ketogenic Diet
    • San Diego, California
      University of California San Diego
    Aug 14, 2023

    Advanced Cancers Trial in Houston (PET Scan, FLT)

    Active, not recruiting
    • Advanced Cancers
    • Houston, Texas
      University of Texas MD Anderson Cancer Center
    Dec 16, 2022

    Acute Myeloid Leukemia, Myelodysplastic Syndrome, Myelodysplastic Syndrome With Excess Blasts-2 Trial in United States (drug,

    Active, not recruiting
    • Acute Myeloid Leukemia
    • +2 more
    • Anchorage, Alaska
    • +506 more
    Jan 28, 2023

    AML, FLT3-ITD Mutation Trial in Hong Kong (Quizartinib, Omacetaxine Mepesuccinate Injection)

    Unknown status
    • AML
    • FLT3-ITD Mutation
    • Hong Kong, Hong Kong
      The University of Hong Kong
    Dec 9, 2020

    Previously Untreated Acute Myeloid Leukemia Trial in United States (biological, other, drug)

    Recruiting
    • Previously Untreated Acute Myeloid Leukemia
    • Samalizumab (BAML-16-001-S1)
    • +32 more
    • Phoenix, Arizona
    • +18 more
    Oct 17, 2022

    Brain and CNS Tumors, Chronic Myeloproliferative Disorders, Leukemia Trial in Detroit (3'-deoxy-3'-[18F]fluorothymidine)

    Recruiting
    • Brain and Central Nervous System Tumors
    • +8 more
    • 3'-deoxy-3'-[18F]fluorothymidine
    • Detroit, Michigan
      Barbara Ann Karmanos Cancer Institute
    Mar 30, 2022